GSK To Supply Combivir For NIH Trial Following Letter From Rep. Waxman
Executive Summary
GlaxoSmithKline will provide Combivir at a discounted rate for a clinical trial on HIV treatment in developing countries following a letter from Rep. Henry Waxman (D-Calif.) admonishing the company for withdrawing from the study